1. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–65.
2. Fayyad J. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–9.
3. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. NICE guidelines [CG72]. 2008. https://www.nice.org.uk/guidance/cg72 . Accessed 7 Dec 2015.
4. All Wales Therapeutics and Toxicology Centre. AWMSG secretariat assessment report: Lisdexamfetamine dimesylate (Elvanse Adult®) 30 mg, 50 mg and 70 mg hard capsules. Reference number: 2534. 2015. http://www.awmsg.or . Accessed 14 Dec 2015.
5. Kolar D, Keller A, Golfinopoulos M, et al. Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat. 2008;4(2):389–403.